Midst of the global COVID-19 pandemic, a controversial narrative has emerged, suggesting that hospitals might have prioritized profit over patient care. The claim suggests a correlation between the number of COVID-19 patient fatalities and financial gains for medical institutions. Concurrently, there is an intriguing revelation regarding the efficacy of ivermectin as a treatment for COVID-19, challenging the prevailing discourse.
Ivermectin’s Efficacy Unveiled
A recent study published in the Journal of Infection has shed light on the potential benefits of ivermectin in treating COVID-19. Contrary to the portrayal of ivermectin as a “dangerous horse dewormer,” the study indicates that individuals testing positive for COVID-19 and treated with ivermectin experienced a faster recovery. The median recovery time was notably two days shorter than those who did not receive this treatment.
Furthermore, the study revealed a marked difference in hospitalization or mortality rates, with only 1.6% of ivermectin recipients facing such outcomes, compared to 4% in the comparison group. These findings raise questions about the comparative effectiveness of widely promoted COVID-19 vaccines.
More Read
Unraveling the Vilification of Ivermectin
Despite these compelling findings, ivermectin has faced substantial vilification, particularly in the context of its portrayal as an alternative treatment to COVID-19. The allegation is that the disparagement of ivermectin was orchestrated to safeguard the Emergency Use Authorization (EUA) granted to COVID-19 vaccines.
The EUA stipulates that for the FDA to grant authorization, there must be no other suitable alternative for diagnosing, preventing, or treating the disease. The implication is that the widespread acceptance of ivermectin’s efficacy could challenge the exclusivity granted to COVID-19 vaccines, leading to a deliberate effort to undermine its credibility.
The Human Toll
Dr. Pierre Kory, a critical care physician, has been vocal about the consequences of discrediting ivermectin. According to Dr. Kory, the vilification of this treatment option has resulted in the unnecessary loss of millions of lives globally.
As the discourse surrounding COVID-19 treatments continues to evolve, it is crucial to critically assess the available evidence, engage in open dialogue, and remain vigilant to ensure the most effective and ethical approaches to managing the ongoing health crisis. The quest for truth and effective solutions remains paramount in navigating these complex issues.
